Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 18;17(1):64.
doi: 10.1186/s12954-020-00409-9.

A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South

Affiliations

A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South

Jacqueline E Sherbuk et al. Harm Reduct J. .

Abstract

Background: Most people diagnosed with hepatitis C virus (HCV) have not linked to care, despite the availability of safe and effective treatment. We aimed to understand why people diagnosed with HCV have not pursued care in the non-urban Southern United States.

Methods: We conducted a survey and semi-structured interview with participants referred to an HCV clinic who did not attend an appointment between 2014 and 2018. Our clinic is located in a non-urban region of Virginia at a university hospital. Qualitative data collection was guided by the Health Belief Model (HBM). Data was analyzed using qualitative content analysis to identify key factors influencing patient perceptions regarding HCV and pursuit of care.

Results: Over half of previously referred patients (N = 200) could not be reached by phone. Eleven participants enrolled, including 7 men and 4 women. Based on survey responses, unreliable transportation, unstable housing, substance use, and lack of insurance were common. Participants demonstrated good knowledge of HCV disease, complications, and treatment. On qualitative analysis of semi-structured interviews, final themes emerged from within and between HBM constructs. Emerging themes influencing patient perceptions included (1) structural barriers, (2) stigma, (3) prior experiences of HCV disease and treatment, (4) discordance between the recognized severity of HCV and expected impacts on one's own health, and (5) patient-provider relationship. Substance use was not identified to be a barrier to care.

Conclusions: Participants perceived individual and structural barriers to linking to care. A strong HCV knowledge base was not sufficient to motivate pursuit of care. Efforts to improve linkage to care must address barriers at multiple levels, and system-level changes are needed. As the majority of previously referred patients could not be contacted by phone, current approaches to patient engagement are not effective for reaching these populations. Expansion of HCV care to primary care settings with an established patient-provider relationship or co-located treatment within substance use treatment programs may serve to increase access to HCV treatment.

Keywords: Content analysis; Health Belief Model; Hepatitis C; Linkage to care; Stigma; Substance use.

PubMed Disclaimer

Conflict of interest statement

KAM reports stock ownership in Gilead Sciences, Inc. RD provides consulting services for Warm Health Technologies, an mHealth company. RD and KAM are recipients of an investigator-initiated grant from Gilead Sciences, Inc. All other authors declare no competing interests.

Similar articles

Cited by

References

    1. National Academies of Sciences Engineering and Medicine. A national strategy for the elimination of hepatitis B and C: phase two report [Internet]. Washington DC; 2017 [cited 2019 Sep 27]. Available from: http://www.nationalacademies.org/hmd/reports/2017/national-strategy-for-....
    1. World Health Organization. Hepatitis C [Internet]. [cited 2019 Nov 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
    1. Younossi Z, Papatheodoridis G, Cacoub P, Negro F, Wedemeyer H, Henry L, et al. The comprehensive outcomes of hepatitis C virus infection: a multi-faceted chronic disease. J Viral Hepat. 2018;25:6–14. doi: 10.1111/jvh.13005. - DOI - PubMed
    1. Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study. Lancet Infect Dis. 2018;18(2):215–224. doi: 10.1016/S1473-3099(17)30676-X. - DOI - PMC - PubMed
    1. Jordan AE, Perlman DC, Reed J, Smith DJ, Hagan H. Patterns and gaps identified in a systematic review of the hepatitis C virus care continuum in studies among people who use drugs. Front Public Heal [Internet]. 2017 Dec 18 [cited 2020 Apr 11];5:348. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29326922. - PMC - PubMed

Publication types